Literature DB >> 8764928

Immunolocalization of cathepsin D in pneumocytes of normal human lung and in pulmonary fibrosis.

M Kasper1, P Lackie, M Haase, D Schuh, M Müller.   

Abstract

Cathepsin D expression has been assessed by immunohistochemistry and immunoelectron microscopy in fetal, normal adult and injured lungs of human beings. In addition to the well known positivity of alveolar macrophages and the bronchial epithelial cells, normal type I and to a lesser extent type II pneumocytes showed a granular, cytoplasmic staining pattern. Using immunogold labelling of lowicryl embedded human lung, cathepsin D was present in lysosomes of epithelial cells. Double immunofluorescence labelling employing type I and type II specific antibodies or lectins confirmed the epithelial staining for cathepsin D. At the terminal sac period during lung development cathepsin D appears in the alveolar epithelium. In fibrotic specimens, enhanced immunoreactivity was found in epithelial and non-epithelial cells. Proliferative epithelial formations were strongly stained with cathepsin D antibodies, whereas detached, desquamated epithelial cells were weakly positive or negative. We suggest that cathepsin D plays a role in the remodelling process during fibrogenesis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8764928     DOI: 10.1007/bf00196692

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  26 in total

1.  Application of cryoultramicrotomy to immunocytochemistry.

Authors:  K T Tokuyasu
Journal:  J Microsc       Date:  1986-08       Impact factor: 1.758

2.  Immunohistological detection of the beta subunit of prolyl 4-hydroxylase in rat and mini pig lungs with radiation-induced pulmonary fibrosis.

Authors:  M Kasper; S D Fuller; D Schuh; M Müller
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

Review 3.  Cathepsin D in the malignant progression of neoplastic diseases (review).

Authors:  G Leto; N Gebbia; L Rausa; F M Tumminello
Journal:  Anticancer Res       Date:  1992 Jan-Feb       Impact factor: 2.480

4.  Use of poly(vinylpyrrolidone) and poly(vinyl alcohol) for cryoultramicrotomy.

Authors:  K T Tokuyasu
Journal:  Histochem J       Date:  1989-03

5.  Immunolocalization of cathepsin D in normal and neoplastic human tissues.

Authors:  W A Reid; M J Valler; J Kay
Journal:  J Clin Pathol       Date:  1986-12       Impact factor: 3.411

6.  Cathepsin D stimulates DNA synthesis and mitosis in mouse liver in vivo.

Authors:  M Morioka; H Terayama
Journal:  Exp Cell Res       Date:  1984-03       Impact factor: 3.905

7.  Changes in biochemical characteristics and pattern of lectin binding of alveolar type II cells with time in culture.

Authors:  L G Dobbs; M C Williams; A E Brandt
Journal:  Biochim Biophys Acta       Date:  1985-07-30

8.  Cathepsin B activity in human lung tumor cell lines: ultrastructural localization, pH sensitivity, and inhibitor status at the cellular level.

Authors:  E Spiess; A Brüning; S Gack; B Ulbricht; H Spring; G Trefz; W Ebert
Journal:  J Histochem Cytochem       Date:  1994-07       Impact factor: 2.479

9.  The human cathepsin D-encoding gene is transcribed from an estrogen-regulated and a constitutive start point.

Authors:  F E May; D J Smith; B R Westley
Journal:  Gene       Date:  1993-12-08       Impact factor: 3.688

10.  Cathepsin B expression and laminin degradation as factors influencing prognosis of surgically treated patients with lung adenocarcinoma.

Authors:  T Inoue; T Ishida; K Sugio; K Sugimachi
Journal:  Cancer Res       Date:  1994-12-01       Impact factor: 12.701

View more
  8 in total

1.  The safety and tolerability of pirfenidone for bronchiolitis obliterans syndrome after hematopoietic cell transplant (STOP-BOS) trial.

Authors:  Efthymia Iliana Matthaiou; Husham Sharifi; Christian O'Donnell; Wayland Chiu; Clark Owyang; Paulami Chatterjee; Ihsan Turk; Laura Johnston; Theresa Brondstetter; Karen Morris; Guang-Shing Cheng; Joe L Hsu
Journal:  Bone Marrow Transplant       Date:  2022-05-31       Impact factor: 5.174

2.  Toxicity of orally inhaled drug formulations at the alveolar barrier: parameters for initial biological screening.

Authors:  Eleonore Fröhlich
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

3.  Angiotensinogen gene transcription in pulmonary fibrosis.

Authors:  Bruce D Uhal; My-Trang T Dang; Xiaopeng Li; Amal Abdul-Hafez
Journal:  Int J Pept       Date:  2012-02-20

4.  M2 macrophages have unique transcriptomes but conditioned media does not promote profibrotic responses in lung fibroblasts or alveolar epithelial cells in vitro.

Authors:  Elissa M Hult; Stephen J Gurczynski; Bethany B Moore
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-07-07       Impact factor: 6.011

5.  Peripheral blood transcriptomic clusters uncovered immune phenotypes of asthma.

Authors:  Hyun Woo Lee; Min-Gyung Baek; Hana Yi; Hye-Ryun Kang; Sungmi Choi; Yoon Hae Ahn; Ji-Young Bang; Kyoung-Hee Sohn; Min-Gyu Kang; Jae-Woo Jung; Jeong-Hee Choi; Sang-Heon Cho
Journal:  Respir Res       Date:  2022-09-08

6.  Impact of cathepsin D activity and C224T polymorphism (rs17571) on chronic obstructive pulmonary disease: correlations with oxidative and inflammatory markers.

Authors:  Sarra Bchir; Soumaya Boumiza; Hela Ben Nasr; Abdelhamid Garrouch; Imen Kallel; Zouhair Tabka; Karim Chahed
Journal:  Clin Exp Med       Date:  2021-02-21       Impact factor: 3.984

7.  The expression and activity of cathepsins D, H and K in asthmatic airways.

Authors:  Alen Faiz; Gavin Tjin; Louise Harkness; Markus Weckmann; Shisan Bao; Judith L Black; Brian G G Oliver; Janette K Burgess
Journal:  PLoS One       Date:  2013-03-06       Impact factor: 3.240

8.  Expression and Localization of Cathepsins B, D, and G in Dupuytren's Disease.

Authors:  Kirin Tan; Helen D Brasch; Bede van Schaijik; James R Armstrong; Reginald W Marsh; Paul F Davis; Swee T Tan; Tinte Itinteang
Journal:  Plast Reconstr Surg Glob Open       Date:  2018-02-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.